Cooley LLP advised Immatics on the deal.Immatics, a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, announced its license, development and…
Immatics’ License Agreement With Bristol Myers Squibb
